Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Long-term use may be required to maintain weight loss, which has cost and ongoing commitment implications
Liver and kidney: ALT, AST, GGT, creatinine, eGFR
Eli Lilly Announces Positive Phase 3 Results for Retatrutide (TRIUMPH-2 & TRIUMPH-3) 23 July,2026 Eli Lilly and Company has announced positive topline results from two additional pivotal Phase 3 obesity trials, further strengthening the evidence for retatrutide, the investigational GIP/GLP-1/Glucagon triple receptor agonist
combinations have never been studied for safety or effectiveness with semaglutide
Steroids mimic hormones directly, acting as a replacement without stimulating the body to release its own hormones
US$ 27.68
US$ 27.55
US$ 25.87
US$ 22.02
US$ 29.79
